Related Experiment Video

Updated: Aug 11, 2026

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

Novel immunotherapeutic approaches to glioma

Ryuya Yamanaka1

  • 1Niigata University, Brain Research Institute, Department of Neurosurgery, Asahimachi-dori 1-757, Niigata City 951-8585, Japan. ryaman@bri.niigata-u.ac.jp

Current Opinion in Molecular Therapeutics
|March 2, 2006
PubMed

Insights

Dendritic cell and peptide immunotherapy shows promise for treating malignant glioma, offering a potentially safe and effective new treatment option. This approach aims to boost the immune system to fight brain tumors and improve patient survival rates.

Area of Science:

  • Neuro-oncology
  • Immunotherapy
  • Cancer Research

Background:

  • Malignant glioma has a poor prognosis despite current treatments like radiation, chemotherapy, and surgery.
  • There is a critical need for novel therapeutic strategies to improve outcomes for glioma patients.

Purpose of the Study:

  • To review the progress and potential of dendritic cell- and peptide-based immunotherapy for malignant glioma.
  • To evaluate the safety and efficacy of these immunotherapeutic approaches in glioma treatment.

Main Methods:

  • Review of current literature on dendritic cell- and peptide-based immunotherapies for glioma.
  • Analysis of reported anti-glioma immune responses and clinical outcomes.

Main Results:

  • Systemic immunotherapy using dendritic cells and peptides can induce an anti-glioma immune response.
  • These immunotherapy strategies appear safe with no major side effects.
  • The approach shows promise in increasing survival for glioma patients.

Conclusions:

  • Dendritic cell- and peptide-based immunotherapy represent a promising novel treatment paradigm for malignant glioma.
  • This biotherapy approach has the potential to induce antitumor immune responses and improve survival.
  • The therapy is considered safe and well-tolerated in patients with glioma.

More Related Videos

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations04:46

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Published on: February 24, 2023

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...